- Home
- About Us
- Information for Patients
- Information for Clinics
- Contact Us
- Find a Clinic
- Press Releases
Information for Clinics
Bringing Light-Based Aesthetic Treatments to the Mass Market
In 1996, Palomar initiated a drive to bring light-based treatments to a larger group of professionals. It was a risky proposition back then. Lasers at that time were very large, expensive, inefficient, and difficult to operate. As a result, only the most experienced and specialized physician offices could afford or operate these complex early lasers. This left a vast, untapped population of physicians and medical spa operators, which Palomar was determined to reach with light-based aesthetic procedures.
To that end, we aligned ourselves with the best clinical research facilities in the world and our research soon paid off with a number of innovative achievements. Among them, the first FDA clearances for:
- Light-based "permanent hair reduction".
- Diode laser application.
- Long pulse application.
This period of research and development culminated with the introduction of the EsteLux® Pulsed Light System in 2001.
A New Approach
With the EsteLux, Palomar pioneered a modular approach, allowing users to purchase the compact but powerful EsteLux console, and to build a treatment repertoire by adding specialized Lux handpieces.
The EsteLux was quickly followed by the higher powered MediLux®, and most recently by the StarLux® Pulsed Light and Laser System, the most powerful and versatile aesthetic system available.
In addition to several pulsed light handpieces for permanent hair reduction, photofacials, and acne, the StarLux features the Lux1540 Fractional™ Laser Handpiece for Soft Tissue Coagulation and Skin Resurfacing, the LuxIR Fractional™ Infrared Handpiece for Skin Tightening through soft tissue coagulation, and the Lux1064™ Nd:YAG Laser Handpiece for Leg Vein Treatment.
Palomar was also awarded a $2.5 million research contract by the Department of the Army to develop a light-based self-treatment device for the dermatologic disease Pseudofolliculitis Barbae (PFB). These are just a few of the innovative applications that Palomar is working on in order to bring light-based treatments to ever larger markets.